nephropathy

nephropathy

1. The level of ET was significantly higher in diabetic nephropathy than that in the control group( P<0.01), and there was positive correlationbetween ET and uAER(r=0.591,P<0.01).

2型糖尿病肾病患者血浆ET水平明显高于正常对照组(P<0.01),ET与uAER呈显著正相关关系(r=0.591,P<0.01)。

2. Patients less than 60 years of age chiefly die of diabetic nephropathy, diabetic ketoacidosis and diabetic peripheral circulatory disorders.

69/10万。<60岁死亡的病人主要死于肾病、酮症酸中毒、周围循环障碍。

3. The expression of CTGF and FN in human mesangial cells is upregulated by AGEs,which may have potential effects in the pathgenic mechanism of diabetic nephropathy.

AGEs可导致人肾小球系膜细胞CTGF和FN mRNA的表达增加,在糖尿病肾病的发生、发展中起一定作用。

4. Biostratum is the manufacturer of a pyridoxamine-based drug called Pyridorin designed to prevent the progression of diabetic nephropathy (kidney disease).

Biostratum是一家专门制作吡哆胺类药物的企业，该公司生产的药物Pyridorin是专门治疗糖尿病肾病的。

5. IgA nephropathy be taken into consideration.

IgA肾病

6. The clinical manifestations and pathological changes of MM patients with renal lesion and cast nephropathy have some common features.

MM伴肾损害、管型肾病患者其临床表现与病理改变均有一定的特点

7. The main death cause of type 1 diabeticswas uremia caused by diabetes nephropathy (DN).

T1DM患者主要死亡原因为糖尿病肾病尿毒症(40%)。

8. There was a linear positive correlation between TCSS grading of neuropathy and the grading of diabetic nephropathy and diabetic retinopathy(P<0.05).

TCSS神经病变分级与糖尿病肾病、糖尿病视网膜病变的分期呈线性正相关（P<0.05）；

9. BACKGROUND: The course of idiopathic membranous nephropathy (iMN) is ariable in untreated patients.

介绍:对于未做治疗的病人,特发性膜性肾病的进展是因人而异的.

10. Introduction: Use of radiographic contrast media can result in an acute toxic nephropathy, especially in patients with renal impairment caused by diabetic nephropathy.

介绍：使用放射造影剂可能引起急性肾毒性（急性中毒性肾病），特别是在由糖尿病肾病引起的肾功能损害的病人中。

11. Alexopoulos E Papa Gianni A Papadimitriou M Ls membranous nephropathy only a glomrular disease[J]. Renal Failure 1998:20:1.

余凌，李惊子，王海燕，等.黄芪当归在肾脏疾病中的应用及其机制研究进展[J].中国中西医结合杂志,2001,21（5）:396.

12. The etiology is unknown.The mode of genetic transmission in idiopathic multicentric osteolysis and its association with nephropathy are variable.

其特徵为渐进且广泛的溶骨变化，最常从腕骨及附骨开始发生，通常没有炎症反应伴随。

13. Praga M.Therapeutic measures in proteinuric nephropathy[J].Kidney Int Suppl,2005(99):s137-s141.

刘必成,李敏侠.肾素血管紧张素系统阻断的肾保护作用[J].中华肾脏病杂志,2007,23(2):129-132.

14. ObjectiveDiabetic nephropathy (DN) is the the frequent extremely complication of type 2 diabetes mellitus,is one of the main cause of death in type 2 diabetic patients aslo.

前言糖尿病肾病(DN)是2型糖尿病(DM)最常见的并发症,也是2型糖尿病病人主要的死亡原因之一。

15. It was also demonstrated that irbesartan had the renal protective effects and could reduce the progression of diabetic nephropathy.

厄贝沙坦另有重要的肾脏保护作用,可延迟糖尿病肾病的发生。

16. Primary disease: 16 patients were chronic glomerulonephritis, 19 patients were diabetic nephropathy (DN) and 18 patients were hypertention nephritis.

原发病:慢性肾小球肾炎16例,糖尿病肾病19例,高血压肾病18例。

17. In addition, the pathology of the Aristolochinc Acid Nephropathy was briefly introduced.

同时对马兜铃酸肾病的病理表现做一简要的介绍。

18. Nagai T,Tomizama T,Mori M.Effect of pancreatic elastase on diabetic nephropathy[J].Diabetes care,1993,8:1212.

吴石白,朱西娥.胰激肽释放酶片治疗糖尿病肾病白蛋白尿20例临床观察[J].中国糖尿病杂志,1999,7:237.

19. For this reason, we sureyed 149 patients with biopsy-proen diabetic nephropathy (DN).

因此，我们调查了149名经活组织检查证明患有糖尿病性肾病（DN）的患者。

20. In India, diabetic nephropathy is expected to deelop in 6.6 million of the 30 million patients with diabetes.

在印度，预计3千万糖尿病患者中，将有6600000人发生糖尿病肾病。

21. Based on a great deal of etiological research, scholars in our country alleged it should be named by "Aristolochic Acid Nephropathy"(AAN) rather than CHN.

在大量病因学研究基础上，我国学者提出“中草药肾病”的命名欠妥，应称之为马兜铃酸肾病(Aristolochic Acid Nephropathy，AAN)。

22. By excluding other secondary causes of minimal-change nephrotic syndrome, lung cancer appeared to be the most probable cause of the IgM nephropathy.

在排除其他引起微小病变肾病症候群的原因之后，我们认为此病患的肺癌和M型免疫球蛋白肾病变有强烈相关性。

23. In the present study, we tested the hypothesis that TZD prevents the progression of diabetic nephropathy by modulating the inflammatory process.

在本研究中，我们测试了以下假设：TZD通过调节炎症发生过程可预防糖尿病肾病的进展。

24. Among diabetic microvessel complications, diabetic nephropathy (DN) is a major cause of mobility and mortality in diabetes mellitus.

在糖尿病诸多微血管并发症之中，糖尿病肾病（diabetic nephropathy，DN）是糖尿致死致残的主要原因之一。

25. CDFI has important clinical values in the early diagnosis, prevention and therapeutic effect as well as prognosis of lower limb arteriosclerosis of diabetic nephropathy.

如果进一步从糖尿病的病程、血糖控制程度、肾病严重程度与下肢动脉硬化严重程度之间进行关联性探讨，则更能全面体现其临床应用价值。

26. They are glomerular nephropathy with the disease, peripheral and central nervous system lesions, skin rashes, Raynaud's phenomenon of the pathological basis.

它们是本病并发肾小球肾病、周围及中枢神经系统病变、皮疹、雷诺氏现象的病理基础。

27. Objective: Observe the curative effect of JST withhighs medium and low dosage on the model of rat membranous nephropathy(MN) compared with SYSWT and the doseffect relationship.

实验一研究目的：采用C-BSA制作大鼠膜性肾病模型，以肾炎四味片为对照，观察健肾片高、中、低剂量组对该模型的疗效及量效关系。

28. Are there any difference between ACEI and ARBs in patients with diabetes nephropathy, does ARB have priority for management of nephropathy patients with type 2 diabetes?

对于患有糖尿病肾病的病人而言，ACEI类药物和ARB类药物有多少区别？对于患有2型糖尿病的病人，ARB是否应作为首选药物？

29. The article induced 9 viewpoints to pathogenesy of nephropathy caused by aristolochic acid and reviewed the clinical stage and curing of aristolochic acid nephropathy.

对药用植物中马兜铃酸导致肾病的发病机制归纳为国内外学者的9种观点,并对马兜铃酸肾病的临床分期和治疗方法作了综述。

30. This paper has studied the structure,method of measurement and clinical application of Aristolochic acids,and also discussed the aristolochic acid nephropathy(AAN).

对马兜铃酸类的结构、检测方法、临床应用及其毒副作用进行了分析,并对马兜铃酸肾病进行了讨论。

31. The recent advances about the action of polypeptide growth factors on apoptosis and interstitial fibrosis in obstructive nephropathy are reviewed.

就近年来多肽生长因子在梗阻肾细胞凋亡、间质纤维化中起作用的研究进展作一综述.

32. Uric acid nephropathy and lupus nephritis are often the cause of renal failure.

尿酸性肾病变和狼疮性肾炎常常是肾衰竭的原因。

33. The term"Chinese Herbs Nephropathy (CHN)"has been widely used in scientific nephrology publication.

当时国际上称这种慢性肾损害为“中草药肾病”(Chinese Herbs Nephropathy, CHN)。

34. It was designated "Chinese Herbs Nephropathy"(CHN) internationally at that time.

当时国际上称这种慢性肾损害为“中草药肾病”(Chinese Herbs Nephropathy，CHN)。

35. A 62-year-old male patient, with no history of gout and renal stone, was admitted because of acute uric acid nephropathy after several days of diarrheal dehydration.

我们报告一个62岁的男性病人，没有痛风及肾结石的病史。因为数天的腹泻性脱水导致高尿酸血症、寡尿性急性肾衰竭而住院。

36. Diagnosis and management experience of gout arthritis and gouty nephropathy patient with uremia are reported in the article.

报道了痛风性关节炎并痛风肾病(肾功能不全尿毒症期)诊断与治疗经验。

37. Controlling blood pressure will help you stae off heart disease, strokes, diabetic nephropathy, and other chronic complications of diabetes.

控制血压可以降低心脏病，卒中，糖尿病肾病及其他慢性糖尿病并发症发生的风险。

38. We considered the expression of MMP-2 was decreased in extracellular matrix(ECM)of diabetic nephropathy.

推想糖尿病肾病的肾组织的细胞外基质(ECM)的堆积与MMP-2表达降低相关。

39. Objective To investigate the effects of treatment with norcantharidin（NCTD） on proteinuria and renal pathology in protein-overload nephropathy rats.

摘要 目的 观察去甲斑蝥素对蛋白负荷肾病大鼠蛋白尿及肾脏病理的影响。

40. Objective To investigate the effect of losartan on urinary podocyte excretion in diabetic nephropathy (DN) patients.

摘要 目的 观测糖尿病肾病(DN)患者尿足细胞排泄特征及氯沙坦对其的干预作用。

41. To analyse the 44 cases of aristolochic acid nephropathy (AAN) in term of pathogeny, clinical symptoms, laboratory results, and some renal pathology.

摘要从近6年收治的肾小管间质性疾病中，筛选出马兜铃酸肾病患者44例。

42. The effect of betel nut chewing lead to oral disease is well-known, but it leading to nephropathy is rarely discussed.

摘要嚼槟榔对口腔的影向广泛的被讨论及研究，而对肾藏方面的讨论极少。

43. Gouty nephropathy is usually a late manifestation of severe gouty arthritis.

摘要痛风性肾病变通常是一个严重性痛风关节炎的晚期表现。

44. Phlegm and blood stasis have close related with diabetic nephropathy (DN).

摘要痰、瘀与糖尿病肾病(DN)有着密切的关系。

45. Objective To explore the effects of baicalin (Bai) on renal function of diabetic nephropathy (DN) rats and on the antioxigenic enzymes levels of actien mechanism.

摘要目的研究黄芩苷对糖尿病肾病(DN)大鼠肾功能的影响，并从抗氧化应激反应的角度探讨其作用机制。

46. Objective: To observe the clinic effect of Chinese medicine treating diabetic nephropathy.

摘要目的：探讨中医药治疗糖尿病肾病的临床疗效。

47. Objective: To explore the curative effect of Zipi Tongluo decoction on incipient diabetic nephropathy (DN).

摘要目的：探讨滋脾通络汤治疗糖尿病早期肾病的临床疗效。

48. Objective: To investigate the urinary carcinoma in patients with aristolochic acid nephropathy (AAN), in order to improve the levels of diagnosis.

摘要目的：探讨马兜铃酸肾病患者伴发泌尿系肿瘤情况，提高认识和诊断水平。

49. Diabetic nephropathy is one of the most serious complications of diabetes mellitus and it seriously endangers people's health.

摘要糖尿病肾病是糖尿病最为严重的并发症之一，严重危害人类的健康。

50. It was the important pathologic basis of diabetic nephropathy that extracellular matrix gradually accumulation.

摘要细胞外基质进行性积聚是导致糖尿病肾病发生、发展的重要病理基础。

51. Abstract： Membranous nephropathy is one of pathology types about adult nephrotic syndrome,clinically attack rate is higher.

摘要： 膜性肾病是成人肾病综合征常见的病理类型之一，临床上发病率较高。

52. This paper reviewed TCMs containing aristolochic acids, the toxicity of aristolochic acids, the pathogenesis and reasons for aristolochic acid nephropathy.

文章综述了含马兜铃酸的中药、马兜铃酸的毒性作用、马兜铃酸肾病发病机制及其原因。

53. Methods: We have established ADR nephropathy model, and measured the expression of CyP gene in ADR nephropathy by RT PCR.

方法 :应用传统的方法首先建立阿霉素肾病模型 ,通过逆转录聚合酶链反应 ( RT- PCR)测定阿霉素肾病肾组织环孢素亲合素基因的表达。

54. Methods By in situ hybridization. EBER1 was detected in renal tissues of 12 IN patients and 10 patients with minimal change nephropathy (MCN) as control group.

方法 用原位杂交方法对12例间质性肾炎患者及10例微小病变肾病患者对照组肾组织石蜡切片进行EB病毒编码的小RNA(EBER1)检测。

55. Methods Serum HA contents were determined with RIA and plasma VEGF with ELISA in 38 patients with chronic nephropathy both before and after treatment as well as in 35 controls.

方法:应用放免法和酶联双抗体法测定38例慢性肾病患者血清HA和血浆VEGF的含量,并以35名正常人作比较。

56. Methods To contrast the 24 hours urinary albumin excretion rate (UAER) and creatimine cleaning rate (Ccr) in 41 diabetic nephropathy patients.

方法对41例糖尿病肾病患者应用凯时治疗前后24小时尿蛋白及肌酐清除率对照。

57. Hyperuricemic nephropathy was thought to be a kind of common diseases in western countries, which was rarely seen in our country in the past.

既往认为高尿酸血症肾病是西方国家的一种常见病,在中国少见。

58. It has been proposed that locally produced MCP-1 may be involved in the development of diabetic nephropathy (DN).

有人提出局部生成的MCP-1可能参与了糖尿病肾病(DN)的发生。

59. Organic solvents related nephrosis(a novel type of toxic nephropathy?

有机溶剂相关性肾病综合征(一种新发现的中毒性肾病?

60. Those with hypertension, cardiopathy, hepatopathy, diabetes, nephropathy and other severe chronic diseases shall take medicine under guidance of physician.

有高血压、心脏病、肝病、糖尿病、肾病等慢性病严重者应在医师指导下服用。

61. Some traditional Chinese medicines (TCM) containing aristolochic acids (AA) will cause Aristolochic Acid Nephropathy (AAN), and this phenomenon has being paid important attention.

某些含马兜铃酸的中药会引起马兜铃酸肾病,这一现象已引起了人们的广泛关注。

62. Idiopathic membranous nephropathy (IMN) remains the most common histologic entity associated with adult-onset nephrotic syndrome.

特发性膜性肾病（IMN）依然是成人肾病综合征的最常见的病理类型。

63. Stenosal incidence: It was higher in the diabetic nephropathy group than that in the normal control group (P <0.05).

狭窄的发生率:糖尿病肾病组高于正常对照组(P<0.05)。

64. Porcine circovirus type 2 (PCV2) is the causative agent of postweaning multisystemic wasting syndrome (PMWS) and porcine dermatitis and nephropathy syndrome (PDNS).

猪圆环病毒2型(PCV2)是引发断奶猪多系统衰竭综合征(PMWS)和猪的皮炎与肾病综合征(PDNS)等有关疾病的重要病原。

65. Wang LH, Liu YN, Guo LZ, et al. The effect of Shenkang injection on extracellular matrix in diabetic nephropathy rat model. Chin J Tradit Med Sci Technol2005;12(2):77-79.

王立红,刘玉宁,郭立中,等.肾康注射液对糖尿病肾病大鼠细胞外基质影响的实验研究.中国中医药科技2005；12()77-79.

66. Agarwal R.Anti-inflammatory effects of shor-term pioglitazone therapy in men with advanced diabetic nephropathy[J].Am J Physiol Renal Physiol,2006,290:600-605.

王静,乔万海.全身炎症反应综合征和多器官功能不全综合征的基因调控和治疗进展[J].中国全科医学,2006,9:1634.

67. This article reviews the relationship between ICAM-1 and Diabetic nephropathy.

现就ICAM-1与糖尿病肾病关系进行综述。

68. Substitution of animal protein by soy prote in results in less hyperfiltration and glomerular hypertension in nephropathy pa tients and protection from nephropathy.

用大豆蛋白代替动物蛋白可减轻高滤过及肾小球高压,对肾脏有保护作用。

69. Due to increasing prevalence rate of diabetes mellitus(DM) and elongation of patiens, diabetic nephropathy(DN) already had become the common complication of DM.

由于糖尿病的患病率不断上升，糖尿病患者寿命的延长，糖尿病肾病(Diabetic Nephropathy，DN)已成为糖尿病最常见的并发症之一。

70. This type of IgA nephropathy is mainly a mixed immuno-complex deposit. The IgA + IgG + IgM deposit bears especially a certain relationship with the prognosis.

病理发现IgA肾病多为混合性免疫复合物沉积,特别是IgA+IgG+IgM的沉积,与预后有一定关系。

71. Gouty nephropathy should be included in the differential diagnosis of an acute decrease in renal function in patients with long-standing gout.

痛风性肾病变也应该列在临床上对于一个长期痛风性关节炎患者身上发生急性肾功能异常的?别诊断之中。

72. Objective Gouty nephropathy patients with cardiac insufficiency is common.

痛风性肾病合并心功能不全是临床常见的表现。

73. Recently, there is few study about the correlation between adiponectin and nephropathy, especially diabetic nephropathy.

目前,国内外关于脂联素与肾病,尤其是糖尿病肾病的研究甚少。

74. Objective To study the significance of urine and serum transferrin (TRF) in earlier diabetic nephropathy.

目的 了解血、尿转铁蛋白的变化在糖尿病肾病中的临床意义。

75. Objective To study the effects and clinical significance of tea pigment on 24 hour urinary endothelin(UET) excretion in patients with early stage diabetic nephropathy.

目的 探讨茶色素对早期糖尿病肾病患者 2 4h尿液内皮素 (UET)排泄的影响及其临床意义。

76. Objective To investigate the pathologic features and diagnostic algorithm of light chain nephropathy (LCN).

目的 探讨轻链肾病 (lightchainnephropathy ,LCN)的病理学特点及其诊断方法。

77. Objective To observe the effect of urokinase(UK) combined with angiotensin converting enzyme inhibitor (ACEI) on IgA nephropathy(IgAN).

目的 观察联合应用尿激酶(UK)和血管紧张素转换酶抑制剂(ACEI)苯那普利治疗IgA肾病(IgAN)的效果。

78. Objective:To analyze the causes of misdiagnosis of amyloid nephropathy.

目的:分析淀粉样变肾病病理误诊的原因。

79. Objective:To study the relationship between metabolic syndrome(MS) and early-stage diabetic nephropathy(DN) in type 2 diabetes mellitus(T2DM).

目的:探讨2型糖尿病(T2DM)合并代谢综合征(metabolic syndrome,MS)与早期糖尿病肾病(diabetic nephropathy,DN)发生的相关性。

80. Objective To investigate the changes of serum HA and plasma VEGF levels after treatment in patients with chronic nephropathy.

目的:探讨了慢性肾病患者血清透明质酸(HA)和血浆血管内皮生长因子(VEGF)水平。